Nureca Limited (NSE:NURECA)
India · Delayed Price · Currency is INR 306.70
-12.80 (-4.01%)
Aug 21, 2026, 3:28 PM IST
Nureca Revenue
Nureca had revenue of 403.43M INR in the quarter ending June 30, 2026, with 18.04% growth. This brings the company's revenue in the last twelve months to 1.53B, up 23.92% year-over-year. In the fiscal year ending March 31, 2026, Nureca had annual revenue of 1.47B with 34.02% growth.
Revenue (ttm)
1.53B
Revenue Growth
+23.92%
P/S Ratio
1.91
Revenue / Employee
9.94M
Employees
154
Market Cap
2.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.47B | 373.02M | 34.02% |
| Mar 31, 2025 | 1.10B | 177.33M | 19.29% |
| Mar 31, 2024 | 919.28M | -193.95M | -17.42% |
| Mar 31, 2023 | 1.11B | -1.44B | -56.44% |
| Mar 31, 2022 | 2.56B | 420.94M | 19.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Haleos Labs | 3.24B |
| Infinium Pharmachem | 1.90B |
| QMS Medical Allied Services | 1.83B |
| Lyka Labs | 1.34B |
Nureca News
- 1 year ago - Nureca shares jump over 3% as Dr Trust & Dr Physio gear up to launch on Swiggy Instamart - Business Upturn
- 2 years ago - Nureca shares surge 6% after company signs distribution agreement - Business Upturn